{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:44:51Z","timestamp":1788011091754,"version":"build-2784847793"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.atherosclerosis.2024.119069","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:08:27Z","timestamp":1732662507000},"page":"119069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Circulatory miRNAs in essential hypertension"],"prefix":"10.1016","volume":"401","author":[{"given":"Daria","family":"Kostiniuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Marttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7023-8706","authenticated-orcid":false,"given":"Emma","family":"Raitoharju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.119069_bib1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib2","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib3","series-title":"Guideline for the Pharmacological Treatment of Hypertension in Adults","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib4","volume":"4","author":"Oparil","year":"2018","journal-title":"Hypertension, Nat Rev Dis Primers"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/HYPERTENSIONAHA.121.18502","article-title":"Hypertension-mediated organ damage: prevalence, correlates, and prognosis in the community","volume":"79","author":"Vasan","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2005.09.002","article-title":"Mechanisms of target organ damage caused by hypertension: therapeutic potential","volume":"111","author":"Cohuet","year":"2006","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib7","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41371-019-0253-4","article-title":"Heritability of blood pressure traits in diverse populations: a systematic review and meta-analysis","volume":"33","author":"Kolifarhood","year":"2019","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11357-022-00699-w","article-title":"Dilated hypertrophic phenotype of the carotid artery is associated with accelerated age-associated central arterial stiffening","volume":"45","author":"AlGhatrif","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cvr\/cvy009","article-title":"Smooth muscle cell and arterial aging: basic and clinical aspects","volume":"114","author":"Lacolley","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","article-title":"The different facets of dyslipidemia and hypertension in atherosclerosis","volume":"18","author":"Hurtubise","year":"2016","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib12","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pcad.2019.11.002","article-title":"Systemic hemodynamic atherothrombotic syndrome (SHATS) \u2013 coupling vascular disease and blood pressure variability: proposed concept from pulse of Asia","volume":"63","author":"Kario","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating MicroRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib15","doi-asserted-by":"crossref","first-page":"H1486","DOI":"10.1152\/ajpheart.00888.2020","article-title":"Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers","volume":"320","author":"Tan","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11906-016-0696-8","article-title":"Role of MicroRNA in endothelial dysfunction and hypertension","volume":"18","author":"Nemecz","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/jhh.2014.99","article-title":"The emerging role of non-coding RNA in essential hypertension and blood pressure regulation","volume":"29","author":"Marques","year":"2015","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41440-018-0071-z","article-title":"microRNA-21 and hypertension","volume":"41","author":"Li","year":"2018","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2023.2288741","article-title":"Recent progress in miRNA biogenesis and decay","volume":"21","author":"Bofill-De Ros","year":"2024","journal-title":"RNA Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib24","doi-asserted-by":"crossref","first-page":"a032771","DOI":"10.1101\/cshperspect.a032771","article-title":"Mechanistic insights into MicroRNA-mediated gene silencing","volume":"11","author":"Duchaine","year":"2019","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1261\/rna.2183803","article-title":"A uniform system for microRNA annotation","volume":"9","author":"Ambros","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nbt.3947","article-title":"An integrated expression atlas of miRNAs and their promoters in human and mouse","volume":"35","author":"Fantom Consortium","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib29","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41598-020-62534-6","article-title":"The relationship of human tissue microRNAs with those from body fluids","volume":"10","author":"Cui","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib30","article-title":"Comparing the MicroRNA spectrum between serum and plasma","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib32","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/CIRCULATIONAHA.110.012237","article-title":"Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection","volume":"124","author":"Li","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib35","doi-asserted-by":"crossref","first-page":"E2271","DOI":"10.1210\/jc.2012-1996","article-title":"Circulating miRNA profiles in patients with metabolic syndrome","volume":"97","author":"Karolina","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijcard.2014.09.204","article-title":"MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation","volume":"177","author":"Yang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-019-1028-1","article-title":"Screening of differentially expressed microRNAs of essential hypertension in Uyghur population","volume":"18","author":"Ye","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.645541","article-title":"MicroRNA profiles in normotensive and hypertensive South African individuals","volume":"8","author":"Matshazi","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11262-018-1532-9","article-title":"Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction","volume":"54","author":"Shen","year":"2018","journal-title":"Virus Gene."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/jhh.2016.66","article-title":"Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis","volume":"31","author":"Huang","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41598-021-04341-1","article-title":"Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.710438","article-title":"Circulating levels of MicroRNAs associated with hypertension: a cross-sectional study in male and female South African participants","volume":"12","author":"Matshazi","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jash.2014.03.324","article-title":"MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage","volume":"8","author":"Kontaraki","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/HJH.0000000000002606","article-title":"Association between circulating vascular-related microRNAs and an increase in blood pressure: a 5-year longitudinal population-based study","volume":"39","author":"Suzuki","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/1354750X.2022.2070281","article-title":"Circulating microRNA-27a and -133a are negatively associated with incident hypertension: a five-year longitudinal population-based study","volume":"27","author":"Suzuki","year":"2022","journal-title":"Biomarkers"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib46","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2018.5733","article-title":"Overexpression of microRNA-506-3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression","author":"Yi","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib47","article-title":"Molecular mechanisms in vascular injury induced by hypertension: expression and role of microRNA-34a","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41371-018-0061-2","article-title":"Association between hypertension and circulating vascular-related microRNAs","volume":"32","author":"Hijmans","year":"2018","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib49","first-page":"11761","article-title":"Correlation between serum microRNA-136 levels and RAAS biochemical markers in patients with essential hypertension","volume":"24","author":"Chu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/hr.2016.147","article-title":"Expression and methylation of circulating microRNA-510 in essential hypertension","volume":"40","author":"Krishnan","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib51","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/jch.13704","article-title":"Down\u2010regulation of miRNA 145 and up\u2010regulation of miRNA 4516 may be associated with primary hypertension","volume":"21","author":"\u00d6zkan","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mgene.2018.01.011","article-title":"Association between serum microRNA-605 and microRNA-623 expression and essential hypertension in Egyptian patients","volume":"16","author":"Badawy","year":"2018","journal-title":"Meta Gene"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00969","article-title":"Differential expression of MicroRNA let-7e and 296-5p in plasma of Egyptian patients with essential hypertension","volume":"4","author":"Badawy","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib54","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1097\/MD.0000000000000693","article-title":"Differential expression of hypertension-associated MicroRNAs in the plasma of patients with white coat hypertension","volume":"94","author":"Cengiz","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/jhh.2017.52","article-title":"Plasma expression level of miRNA let-7 is positively correlated with carotid intima-media thickness in patients with essential hypertension","volume":"31","author":"Huang","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib56","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/0886022X.2021.1915800","article-title":"MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone","volume":"43","author":"Kara","year":"2021","journal-title":"Ren. Fail."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/10641963.2015.1036064","article-title":"Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension","volume":"37","author":"Cengiz","year":"2015","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017297","article-title":"Circulating miR-21 levels in hypertensive patients with asymptomatic organ damage","volume":"98","author":"Yildirim","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib59","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/jhh.2013.117","article-title":"Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension","volume":"28","author":"Kontaraki","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jash.2015.07.013","article-title":"Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension","volume":"9","author":"Kontaraki","year":"2015","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/10641963.2016.1226889","article-title":"Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy","volume":"39","author":"Huang","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib62","article-title":"MiR-103a targeting Piezo1 is involved in acute myocardial infarction through regulating endothelium function","author":"Huang","year":"2016","journal-title":"Cardiol. J."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib63","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41440-020-0405-5","article-title":"The circulating level of miR-122 is a potential risk factor for endothelial dysfunction in young patients with essential hypertension","volume":"43","author":"Zhang","year":"2020","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib64","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/10641963.2015.1116551","article-title":"Circulating miR155 expression level is positive with blood pressure parameters: potential markers of target-organ damage","volume":"38","author":"Huang","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41371-018-0123-5","article-title":"Platelet microRNAs in hypertensive patients with and without cardiovascular disease","volume":"33","author":"Marketou","year":"2019","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib66","article-title":"Blood microRNA 202-3p associates with the risk of essential hypertension by targeting soluble ST2","volume":"40","author":"Li","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/10641963.2019.1571597","article-title":"A potential risk factor of essential hypertension in case-control study: MicroRNAs miR-10a-5p","volume":"42","author":"Luo","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib68","first-page":"41","volume":"19","author":"Xin","year":"2024","journal-title":"The Association of Micro-RNA 21 and Hypertension: A Meta-Analysis, Gh"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib69","article-title":"Pathological hyperinsulinemia and hyperglycemia in the impaired glucose tolerance stage mediate endothelial dysfunction through miR-21, PTEN\/AKT\/eNOS, and MARK\/ET-1 pathways","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib70","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2010.02.045","article-title":"MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity","volume":"393","author":"Weber","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib71","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1073\/pnas.1107052108","article-title":"MicroRNA-21 targets peroxisome proliferators-activated receptor-\u03b1 in an autoregulatory loop to modulate flow-induced endothelial inflammation","volume":"108","author":"Zhou","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib72","first-page":"2216","article-title":"Effects of MiR-21 on the proliferation and migration of vascular smooth muscle cells in rats with atherosclerosis via the Akt\/ERK signaling pathway","volume":"23","author":"Sun","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib73","article-title":"Mechanical stretch modulates MicroRNA 21 expression, participating in proliferation and apoptosis in cultured human aortic smooth muscle cells","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2022.02.018","article-title":"OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186\u20135p then inactivating SHIP2 mediated PI3K\/AKT\/mTOR pathway","volume":"146","author":"Ren","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib75","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.7150\/thno.37357","article-title":"Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p\/PTEN-mediated VSMC migration and proliferation","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib76","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","article-title":"MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation","volume":"100","author":"Ji","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib78","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3892\/mmr.2014.3107","article-title":"MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway","volume":"11","author":"Cao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.81","article-title":"MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort","volume":"47","author":"Han","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib80","doi-asserted-by":"crossref","first-page":"7823","DOI":"10.1038\/s41598-018-25690-4","article-title":"MicroRNA expression profile of human advanced coronary atherosclerotic plaques","volume":"8","author":"Parahuleva","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib81","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics","volume":"20","author":"Bautista-S\u00e1nchez","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib82","first-page":"1","article-title":"miR-30 family: a promising regulator in development and disease","volume":"2018","author":"Mao","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib83","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1160\/TH11-09-0607","article-title":"microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans","volume":"107","author":"Bidzhekov","year":"2012","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib84","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/HYPERTENSIONAHA.115.05645","article-title":"Endogenous MicroRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes","volume":"66","author":"Kriegel","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib85","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1182\/blood-2012-04-423004","article-title":"The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis","volume":"120","author":"Bridge","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib86","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.113.01767","article-title":"miR-30a regulates endothelial tip cell formation and arteriolar branching","volume":"62","author":"Jiang","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib87","doi-asserted-by":"crossref","first-page":"45200","DOI":"10.18632\/oncotarget.16778","article-title":"Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yjmcc.2015.10.009","article-title":"MicroRNA-30 mediates anti-inflammatory effects of shear stress and KLF2 via repression of angiopoietin 2","volume":"88","author":"Demolli","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib89","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fmed.2019.00280","article-title":"Hypertension associated with hyperlipidemia induced different MicroRNA expression profiles in plasma, platelets, and platelet-derived microvesicles; effects of endothelial progenitor cell therapy","volume":"6","author":"Alexandru","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymthe.2019.09.008","article-title":"Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis","volume":"28","author":"Xu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib91","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1007\/s00018-021-03979-4","article-title":"MicroRNA-34a: the bad guy in age-related vascular diseases","volume":"78","author":"Raucci","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib92","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.154252","article-title":"Shear-sensitive MicroRNA-34a modulates flow-dependent regulation of endothelial inflammation","author":"Fan","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib93","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"447","author":"He","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib94","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/gerona\/glu180","article-title":"MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors","volume":"70","author":"Badi","year":"2015","journal-title":"GERONA"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib95","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/acel.12615","article-title":"Kallistatin reduces vascular senescence and aging by regulating micro RNA \u201034a\u2010 SIRT 1 pathway","volume":"16","author":"Guo","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib96","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00192.2010","article-title":"MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1","volume":"299","author":"Zhao","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib97","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.3390\/ijms21124454","article-title":"The microRNA-34a-induced senescence-associated secretory phenotype (SASP) favors vascular smooth muscle cells calcification","volume":"21","author":"Zuccolo","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib98","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00380-018-1169-6","article-title":"Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2","volume":"33","author":"Su","year":"2018","journal-title":"Heart Ves."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib99","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.114.013675","article-title":"Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of MicroRNA-92a","volume":"131","author":"Chen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib100","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2013.204917","article-title":"MicroRNAs in the atheroclerotic plaque","author":"Raitoharju","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib101","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.110.005108","article-title":"Flow-Dependent regulation of kr\u00fcppel-like factor 2 is mediated by MicroRNA-92a","volume":"124","author":"Wu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib102","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvu162","article-title":"Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury","volume":"103","author":"Daniel","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib103","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.118.314010","article-title":"Atherosclerotic conditions promote the packaging of functional MicroRNA-92a-3p into endothelial microvesicles","volume":"124","author":"Liu","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib104","article-title":"Preliminary study of microRNA-126 as a novel therapeutic target for primary hypertension","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2023.04.013","article-title":"High miR-126-3p levels associated with cardiovascular events in a general population","volume":"113","author":"Martinez-Arroyo","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib106","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10735-021-10041-x","article-title":"MicroRNA-126-5p inhibits apoptosis of endothelial cell in vascular arterial walls via NF-\u03baB\/PI3K\/AKT\/mTOR signaling pathway in atherosclerosis","volume":"53","author":"Jia","year":"2022","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2294","article-title":"Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis","volume":"12","author":"Santovito","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib108","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.0707493105","article-title":"MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1","volume":"105","author":"Harris","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/497280","article-title":"miR-126 is involved in vascular remodeling under laminar shear stress","volume":"2015","author":"Mondadori Dos Santos","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib110","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1111\/jcmm.16460","article-title":"miR\u2010126\u20103p is essential for CXCL12\u2010induced angiogenesis","volume":"25","author":"Bassand","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific MicroRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of MicroRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib113","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3487","article-title":"MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1","volume":"20","author":"Schober","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib114","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vph.2018.11.006","article-title":"The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease","volume":"112","author":"Vacante","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating MicroRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib116","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114060","article-title":"rs41291957 controls miR\u2010143 and miR\u2010145 expression and impacts coronary artery disease risk","volume":"13","author":"Hall","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib117","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-4227","article-title":"Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation","volume":"8","author":"Yuan","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib118","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jvs.2015.06.136","article-title":"MicroRNA deregulation in symptomatic carotid plaque","volume":"62","author":"Maitrias","year":"2015","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib119","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/STROKEAHA.110.597575","article-title":"A unique MicroRNA signature associated with plaque instability in humans","volume":"42","author":"Cipollone","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ncb2441","article-title":"Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs","volume":"14","author":"Hergenreider","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib121","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/CIRCRESAHA.113.301282","article-title":"AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143\/145","volume":"112","author":"Kohlstedt","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib122","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","article-title":"MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation","volume":"105","author":"Cheng","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib123","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib124","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13238-015-0212-y","article-title":"Biogenesis and regulation of the let-7 miRNAs and their functional implications","volume":"7","author":"Lee","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejps.2019.02.013","article-title":"Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studies","volume":"131","author":"Solayman","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib126","article-title":"Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib127","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrm3619","article-title":"Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair","volume":"14","author":"Xin","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db16-0731","article-title":"Circulating MicroRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes","volume":"66","author":"Willeit","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/srep38262","article-title":"Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism\u2014the Young Finns Study","volume":"6","author":"Raitoharju","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.arteri.2016.05.005","article-title":"microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers","volume":"28","author":"De Gonzalo-Calvo","year":"2016","journal-title":"Cl\u00edn. Invest. Arterioscler."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/00033197221121617","article-title":"Differences in MicroRNA expression in pericoronary adipose tissue in coronary artery disease compared to severe valve dysfunction","volume":"74","author":"Marketou","year":"2023","journal-title":"Angiology"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib132","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1517\/14728222.2013.745512","article-title":"Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients","volume":"17","author":"Santovito","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib133","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.084186","article-title":"MicroRNA-145 targeted therapy reduces atherosclerosis","volume":"126","author":"Lovren","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib134","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH13-11-0905","article-title":"MiR-143\/145 deficiency attenuates the progression of atherosclerosis in Ldlr-\/- mice","volume":"112","author":"Sala","year":"2014","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib135","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.bbrc.2018.06.075","article-title":"Plasma exosomes regulate systemic blood pressure in rats","volume":"503","author":"Otani","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib136","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/eurheartj\/ehw146","article-title":"Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?","volume":"37","author":"Willeit","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.119069_bib137","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12920-015-0136-7","article-title":"Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study","volume":"8","author":"Ameling","year":"2015","journal-title":"BMC Med. Genom."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:49:56Z","timestamp":1741844996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024012413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":137,"alternative-id":["S0021915024012413"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119069","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulatory miRNAs in essential hypertension","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119069"}}